Loading stock data…
$4.04-0.34 (-7.67%)
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany.
ZeroStack Corp. in the Financial Services sector is trading at $4.04 with a market capitalization of $92M. Wall Street consensus targets $11.00 (1 analysts), implying a +172.6% move over the next 12 months. The stock is currently near its 52-week low of $1.32, remaining 24.9% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $13.66M↑ | $7.27M↓ | $9.35M↓ | $9.75M↑ | $9.71M |
| Gross Profit | $1.62M↓ | $3.15M↑ | $160,000↓ | $335,000↓ | $619,000 |
| Operating Income | -$2.47M↓ | -$1.91M↑ | -$4.80M↓ | -$3.28M↓ | -$1.65M |
| Net Income | -$24.61M↑ | -$36.66M↑ | -$109.90M↓ | -$6.66M↓ | -$2.41M |
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and...